Biolase (NASDAQ:BIOL) is scheduled to announce Q4 earnings results on Thursday, March 21st, after market close. The consensus EPS Estimate is -$0.90 (+29.7% Y/Y) and the consensus Revenue Estimate is ...
Source LinkBiolase (NASDAQ:BIOL) is scheduled to announce Q4 earnings results on Thursday, March 21st, after market close. The consensus EPS Estimate is -$0.90 (+29.7% Y/Y) and the consensus Revenue Estimate is ...
Source Link
Comments